Search results for "FDA update"


 
Results 41 - 50 of about 100 for "FDA update".

First drug in new class approved | ACP Diabetes Monthly

The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and exercise.

Warning about serious genital infections in patients taking SGLT2 inhibitors | ACP Diabetes Monthly

The FDA has identified 12 cases of necrotizing fasciitis of the perineum or Fournier's gangrene. All 12 patients were hospitalized and required surgery, and one died.

New drug approved, meters recalled | ACP Diabetes Monthly

Dapaglifozin (Farxiga), a new medication to treat type 2 diabetes, was recently approved by the FDA for use along with diet and exercise.

Another weight loss drug approved | ACP Diabetes Monthly

A combination of phentermine and topiramate extended-release (Qsymia) was recently approved by the FDA as an addition to a reduced-calorie diet and exercise for chronic weight management.

Liraglutide gets new cardiovascular indication | ACP Diabetes Monthly

The FDA approved a new indication for liraglutide to reduce the risk of myocardial infarction, stroke, and cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Empagliflozin approved to treat type 2 diabetes | ACP Diabetes Monthly

Empagliflozin (Jardiance), a sodium glucose co-transporter 2 inhibitor, was recently approved to treat type 2 diabetes in addition to diet and exercise, the FDA announced last week.

New warnings on medications containing saxagliptin, alogliptin | ACP Diabetes Monthly

New warnings will be placed on saxagliptin and alogliptin about the potential risk of heart failure, particularly in patients with heart or kidney disease, the FDA announced on April 5.

New GLP-1 agonist approved | ACP Diabetes Monthly

A new glucagon-like peptide-1 (GLP-1) receptor agonist, dulaglutide (Trulicity), was approved to treat type 2 diabetes, along with diet and exercise, the FDA recently announced.

Recall, warning, and a new generic drug | ACP Diabetes Monthly

Insulin cartridge holders were recalled, patients were warned about pre-owned test strips, and a generic form of rosiglitazone maleate and metformin hydrochloride was approved.

First continuous glucose monitoring system with fully implantable glucose sensor approved | ACP Diabetes Monthly

The sensor is coated with a fluorescent chemical that produces a small amount of light when exposed to blood glucose. Every five minutes, it sends glucose measurements to a compatible device that is running a device-specific mobile app.

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next